This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed … examination of patent applicants, filing dates, and offices of first and subsequent filing, the paper identifies patterns and …

then, the issue of the relationship between patent protection and the development of and access to medical treatments and … an overview of the patent landscape of medical treatments and technologies related to COVID-19, and of the patent status … of two investigational medical treatments: remdesivir and lopinavir/ritonavir. It then presents various patent …

governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing … countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent … applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …

. It will also question whether biopharmaceutical firms have upheld their end of the patent bargain by adequately …

process from inventor until patent office. University Technology Transfer (TT) is a bit different in comparison to TT at …